Medscape2d
Warning of Confusion Between Nasal and IV Epinephrine
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
Medscape1d
Novel Nasal Device May Help Reduce Monthly Migraines
Kinetic oscillation stimulation for chronic migraine is associated with a significant decrease in monthly headache days vs ...
Inquirer on MSN3d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
BioSpace4d
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
thecardiologyadvisor.com5d
Nasal Spray Formulation of Bumetanide Under FDA Review
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart failure, ...